Myomo Reports Fourth Quarter Year End 2018 Results

CAMBRIDGE, Mass., February 28, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2018 on Thursday, […]

Myomo, Inc. Announces Closing of Public Offering and Full Exercise of Over-Allotment Option

CAMBRIDGE, Mass., February 12, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today has closed its previously announced underwritten public offering of 3,950,000 shares of common stock at an offering price of $1.40 […]

Myomo, Inc. Prices Public Offering of Common Stock

CAMBRIDGE, Mass., February 8, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at an offering […]

Myomo, Inc. Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass., February 7, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an […]

Myomo Announces CFO Succession

February 06, 2019 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo Inc. (NYSE American MYO) (“Myomo,” or the “Company”), a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced that Ralph A. Goldwasser, its Chief Financial Officer, is retiring effective as of February 18, […]

Myomo® to Present at Noble Capital Markets’ 15th Annual Investor Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo,” or the “Company”), a wearable medical robotics company, today announced that it will be presenting at NobleCon15 – Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:30 AM EST – Studio 3. Chairman and Chief Executive […]

Myomo Announces First Adolescent Patients to be Fitted with MyoPro

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc., a wearable medical robotics company, has achieved recent momentum fitting and delivering MyoPro to adolescent users. Approved to assist young adults suffering from any disease or injury leaving them with a paralyzed or weakened arm, MyoPro is restoring motion and functionality to adolescents with conditions such as cerebral palsy, brachial plexus […]

Myomo® Receives Medicare Codes

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo,” or the “Company”), a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services (“CMS”) has published two new codes pursuant to the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December 2017 to have […]

Myomo Announces Third Quarter 2018 Financial Results

CAMBRIDGE, Mass., November 5, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the third quarter ended September 30, 2018. Read more.

Myomo Reports Third Quarter 2018 Results

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that it will release its financial results for the third quarter 2018 on Monday, November 5, 2018, after the US markets close. Read more.